ArticleBritish journal of clinical pharmacology2017

FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms.

Guillermo Moñux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.